A year ago, they were trading at $1.72. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX
Yahoo!5mon
SAN DIEGO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) provides a reminder to stockholders ... each unit consisting of one share of Series B Preferred Stock with a face value of $1000 (and …
SAN DIEGO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (“Cytori”) (NASDAQ:CYTX) announced today the closing of ... of an aggregate of 10,000 shares of Series B Preferred Stock and 18,000,000 warrants, with …
The Company's common stock will continue to trade under the symbol "CYTX" following the transfer of its listing to The NASDAQ Capital Market tier. The continued listing of the Company's common stock on The NASDAQ Capital Market …
Investors in Cytori Therapeutics, Inc. CYTX need to pay close attention to the stock based on moves in the options market lately. That is because the December 15 th, 2017, $2 Call had some of the highest implied volatility of all equity …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX Keywords: Cytori Therapeutics, …